These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 36164623)

  • 1. Expression of Recombinant CTLA-4 and PD-L1 Proteins Fused with Thioredoxin, and Determination of Their Ligand-Binding Activities.
    Zhansaya A; Malika N; Boris D; Kanat T; Kanatbek M; Yerlan R; Kasym M
    Rep Biochem Mol Biol; 2022 Jul; 11(2):310-319. PubMed ID: 36164623
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of Antibody Induction by Macrophages Treated
    Malika N; Zhansaya A; Kasym M; Kanat T; Yerlan R; Kanatbek M
    Rep Biochem Mol Biol; 2023 Jan; 11(4):694-701. PubMed ID: 37131900
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recombinant Expression and Purification of Extracellular Domain of the Programmed Cell Death Protein Receptor.
    Zhansaya A; Kanatbek M; Kanat T; Bakhytkali I; Darkhan K; Arman K; Pavel T; Kasym M; Yerlan R
    Rep Biochem Mol Biol; 2020 Jan; 8(4):347-357. PubMed ID: 32582792
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blocking PD-1/PD-L1 by an ADCC enhanced anti-B7-H3/PD-1 fusion protein engages immune activation and cytotoxicity.
    Xu Y; Xiao Y; Luo C; Liu Q; Wei A; Yang Y; Zhao L; Wang Y
    Int Immunopharmacol; 2020 Jul; 84():106584. PubMed ID: 32422527
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Express the recombinant protein PD-L1 in prokaryotic and analyze its biological activity].
    Shen LP; Chen SY; Bian T; Yi Y; Wang F; Qiu F; Bi SL
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2009 Feb; 23(1):5-7. PubMed ID: 19799003
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Construction of high level prokaryotic expression and purification system of PD-L1 extracellular domain by using Escherichia coli host cell machinery.
    Kalim M; Chen J; Wang S; Lin C; Ullah S; Liang K; Ding Q; Chen S; Zhan J
    Immunol Lett; 2017 Oct; 190():34-41. PubMed ID: 28684274
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased programmed death ligand (PD-L1) and cytotoxic T-lymphocyte antigen-4 (CTLA-4) expression is associated with metastasis and poor prognosis in malignant canine mammary gland tumours.
    Ariyarathna H; Thomson NA; Aberdein D; Perrott MR; Munday JS
    Vet Immunol Immunopathol; 2020 Dec; 230():110142. PubMed ID: 33129194
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulatory mechanisms of immune checkpoints PD-L1 and CTLA-4 in cancer.
    Zhang H; Dai Z; Wu W; Wang Z; Zhang N; Zhang L; Zeng WJ; Liu Z; Cheng Q
    J Exp Clin Cancer Res; 2021 Jun; 40(1):184. PubMed ID: 34088360
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting CD28, CTLA-4 and PD-L1 costimulation differentially controls immune synapses and function of human regulatory and conventional T-cells.
    Dilek N; Poirier N; Hulin P; Coulon F; Mary C; Ville S; Vie H; Clémenceau B; Blancho G; Vanhove B
    PLoS One; 2013; 8(12):e83139. PubMed ID: 24376655
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Programmed death-1 ligand 1 interacts specifically with the B7-1 costimulatory molecule to inhibit T cell responses.
    Butte MJ; Keir ME; Phamduy TB; Sharpe AH; Freeman GJ
    Immunity; 2007 Jul; 27(1):111-22. PubMed ID: 17629517
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of immune checkpoint regulators, cytotoxic T lymphocyte antigen 4 (CTLA-4) and programmed death-ligand 1 (PD-L1), in female breast carcinomas.
    Kassardjian A; Shintaku PI; Moatamed NA
    PLoS One; 2018; 13(4):e0195958. PubMed ID: 29672601
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CTLA-4 Synergizes With PD1/PD-L1 in the Inhibitory Tumor Microenvironment of Intrahepatic Cholangiocarcinoma.
    Guo XJ; Lu JC; Zeng HY; Zhou R; Sun QM; Yang GH; Pei YZ; Meng XL; Shen YH; Zhang PF; Cai JB; Huang PX; Ke AW; Shi YH; Zhou J; Fan J; Chen Y; Yang LX; Shi GM; Huang XY
    Front Immunol; 2021; 12():705378. PubMed ID: 34526987
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PD-L1 Binds to B7-1 Only
    Chaudhri A; Xiao Y; Klee AN; Wang X; Zhu B; Freeman GJ
    Cancer Immunol Res; 2018 Aug; 6(8):921-929. PubMed ID: 29871885
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treg-expressed CTLA-4 depletes CD80/CD86 by trogocytosis, releasing free PD-L1 on antigen-presenting cells.
    Tekguc M; Wing JB; Osaki M; Long J; Sakaguchi S
    Proc Natl Acad Sci U S A; 2021 Jul; 118(30):. PubMed ID: 34301886
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhancement of interleukin-2 production by bovine peripheral blood mononuclear cells treated with the combination of anti-programmed death-ligand 1 and cytotoxic T lymphocyte antigen 4 chimeric monoclonal antibodies.
    Watari K; Konnai S; Okagawa T; Maekawa N; Sajiki Y; Kato Y; Suzuki Y; Murata S; Ohashi K
    J Vet Med Sci; 2022 Jan; 84(1):6-15. PubMed ID: 34789592
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of Immune Checkpoint Regulators, Cytotoxic T-Lymphocyte Antigen-4, and Programmed Death-Ligand 1 in Epstein-Barr Virus-associated Nasopharyngeal Carcinoma.
    Ahmed MM; Gebriel MG; Morad EA; Saber IM; Elwan A; Salah M; Fakhr AE; Shalaby AM; Alabiad MA
    Appl Immunohistochem Mol Morphol; 2021 Jul; 29(6):401-408. PubMed ID: 33480605
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune checkpoint proteins (PD-L1 and CTLA-4) in endometrial carcinoma: prognostic role and correlation with CD4
    Khalifa R; Elsese N; El-Desouky K; Shaair H; Helal D
    J Immunoassay Immunochem; 2022 Mar; 43(2):192-212. PubMed ID: 34697997
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chimeric co-stimulatory molecules that selectively act through CD28 or CTLA-4 on human T cells.
    Lazetic S; Leong SR; Chang JC; Ong R; Dawes G; Punnonen J
    J Biol Chem; 2002 Oct; 277(41):38660-8. PubMed ID: 12167647
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Cloning of the cDNA of human PD-L1 gene and the expression of its extracellular domain in Escherichia coli].
    He XH; Xu LH; Liu Y; Cai XC; Zeng YY
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2004 Nov; 20(6):659-63. PubMed ID: 15555428
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PD-1, PD-L1 and CTLA-4 in pregnancy-related - and in early-onset breast cancer: A comparative study.
    Ács B; Madaras L; Tőkés AM; Kovács AK; Kovács E; Ozsvári-Vidákovich M; Karászi Á; Birtalan E; Dank M; Szász AM; Kulka J
    Breast; 2017 Oct; 35():69-77. PubMed ID: 28651116
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.